Search research articles
Contact Us
Filters
Showing results (61-70 of 97) with videos related to
Page
of 10
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 25, 2003
The value of cardiac enzymes in elderly patients presenting to the emergency department with syncope
Shamai A Grossman, Sara Van Epp, Ryan Arnold, et al.
American Journal of Preventive Medicine
|
September 3, 2017
Characteristics of Adults Who Switched From Cigarette Smoking to E-cigarettes
Su Hyun Park, Dustin T Duncan, Omar El Shahawy, et al.
Neurodegenerative Disease Management
|
October 26, 2022
Characterizing the 'feel-good experience' in multiple sclerosis patients treated with natalizumab or other therapies
John Foley, Regina Berkovich, Mark Gudesblatt, et al.
Ejhaem
|
February 23, 2023
A phase III, randomised, double-blind, multi-national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
Jun Ho Jang, Roberta Demichelis Gomez, Horia Bumbea, et al.
The Journal of Ambulatory Care Management
|
May 22, 2024
Community Health Work and Social Work Collaboration: Integration in Health Care and Public Health Settings: A Conceptual Framework
Liana Petruzzi, Julie Smithwick, Lily Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 1, 2018
Impaired proteostasis in senescent vascular endothelial cells: a perspective on estrogen and oxidative stress in the aging vasculature
HyunTae V Hwang, Yun Lin, Michelle N Rebuffatti, et al.
CNS Drugs
|
August 26, 2018
Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.
CNS Drugs
|
September 24, 2018
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 27, 2005
Sex differences in the emergency department evaluation of elderly patients with syncope
Shamai A Grossman, Nathan I Shapiro, Sara Van Epp, et al.
Advances in Therapy
|
June 23, 2021
Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Jai Perumal, Roumen Balabanov, Ray Su, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 97) with videos related to
Sort By:
Page
of 10
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 25, 2003
The value of cardiac enzymes in elderly patients presenting to the emergency department with syncope
Shamai A Grossman, Sara Van Epp, Ryan Arnold, et al.
American Journal of Preventive Medicine
|
September 3, 2017
Characteristics of Adults Who Switched From Cigarette Smoking to E-cigarettes
Su Hyun Park, Dustin T Duncan, Omar El Shahawy, et al.
Neurodegenerative Disease Management
|
October 26, 2022
Characterizing the 'feel-good experience' in multiple sclerosis patients treated with natalizumab or other therapies
John Foley, Regina Berkovich, Mark Gudesblatt, et al.
Ejhaem
|
February 23, 2023
A phase III, randomised, double-blind, multi-national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
Jun Ho Jang, Roberta Demichelis Gomez, Horia Bumbea, et al.
The Journal of Ambulatory Care Management
|
May 22, 2024
Community Health Work and Social Work Collaboration: Integration in Health Care and Public Health Settings: A Conceptual Framework
Liana Petruzzi, Julie Smithwick, Lily Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 1, 2018
Impaired proteostasis in senescent vascular endothelial cells: a perspective on estrogen and oxidative stress in the aging vasculature
HyunTae V Hwang, Yun Lin, Michelle N Rebuffatti, et al.
CNS Drugs
|
August 26, 2018
Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.
CNS Drugs
|
September 24, 2018
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
Mark Gudesblatt, Karl Wissemann, Myassar Zarif, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
September 27, 2005
Sex differences in the emergency department evaluation of elderly patients with syncope
Shamai A Grossman, Nathan I Shapiro, Sara Van Epp, et al.
Advances in Therapy
|
June 23, 2021
Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Jai Perumal, Roumen Balabanov, Ray Su, et al.
Page
of 10